Michal Andrlik

Sítná Square 3105
Kladno, ST 27201, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Temporal dynamics of lymphocytes in prostate cancer patients treated with proton therapy.

Temporal dynamics of lymphocytes in prostate cancer patients treated with proton therapy.

Journal: Frontiers in oncology

Published: July 26, 2024

Cardiac Conduction System as an OAR in Radiation Therapy: Doses to SA/AV Nodes and Their Reduction.

Cardiac Conduction System as an OAR in Radiation Therapy: Doses to SA/AV Nodes and Their Reduction.

Journal: International journal of particle therapy

Published: June 29, 2024

5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer-A Retrospective Analysis.

5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer-A Retrospective Analysis.

Journal: Cancers

Published: July 28, 2023

Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer-Single Institution Experience.

Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer-Single Institution Experience.

Journal: Cancers

Published: November 16, 2021

Pencil-beam scanning proton therapy for the treatment of glomus jugulare tumours.

Pencil-beam scanning proton therapy for the treatment of glomus jugulare tumours.

Journal: Journal of medical radiation sciences

Published: October 06, 2021

Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.

Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.

Journal: International journal of radiation oncology, biology, physics

Published: July 19, 2021

Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes.

Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes.

Journal: International journal of radiation oncology, biology, physics

Published: November 12, 2020

Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results.

Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results.

Journal: Journal of medical imaging and radiation oncology

Published: February 22, 2019

LOW DOSE BATH FROM IMPT VS. IMXT FOR THE PELVIC AREA WHEN TREATING ADVANCED PROSTATE CANCER.

LOW DOSE BATH FROM IMPT VS. IMXT FOR THE PELVIC AREA WHEN TREATING ADVANCED PROSTATE CANCER.

Journal: Radiation protection dosimetry

Published: January 04, 2019

Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?

Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?

Journal: Practical radiation oncology

Published: October 30, 2018

MEASUREMENT OF SECONDARY NEUTRONS GENERATED DURING PROTON THERAPY.

MEASUREMENT OF SECONDARY NEUTRONS GENERATED DURING PROTON THERAPY.

Journal: Radiation protection dosimetry

Published: August 06, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026